Targeted nanotherapeutic strategy for melanoma using silk-fibroin based artemisinin nanoparticles
Year: 2026
Type: article
Abstract: , which is further corroborated by scratch assay results indicating suppressed cell migration. Collectively, these findings suggest that SF-ARTNPs have strong potential as an effective nanotherapeutic platform for treating malignant melanoma.
Source: RSC Advances
DOI: 10.1039/d6ra04405k
Institutions: Thapar Institute of Engineering & Technology, Virginia Tech
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $1,042
Award: G2769600106
OpenAlex ID: W7202207690
